Protocol No.: VX20-121-104

A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy in Subjects With Cystic Fibrosis
Principal Investigator
Moffett, Kathryn S
Phase
III
Age Group
Both
Applicable Disease Site
Cystic Fibrosis
Participating Institutions
Health Sciences Center
West Virginia University
Contact
Tammy Clark, RN
Study Coordinator/Research Nurse
Phone: +1 304-293-5264

View on ClinicalTrials.gov